![]() |
인쇄하기
취소
|
It is observed that about 30 second-generations of influential pharmaceutical companies in China have visited pharmaceutical companies and hospitals in Korea to discuss investment plans in the beginning of this month.
The visit of 31 second-generations at 26 companies, including the Chinese Big-10 pharmaceutical companies, Tasly Pharmaceutical Group and Buchang Pharmaceutical, was made with 3-...